STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOG

被引：169
|
作者：
OCHIAI, T
NAGATA, M
NAKAJIMA, K
SUZUKI, T
SAKAMOTO, K
ENOMOTO, K
GUNJI, Y
UEMATSU, T
GOTO, T
HORI, S
KENMOCHI, T
NAKAGOURI, T
ASANO, T
ISONO, K
HAMAGUCHI, K
TSUCHIDA, H
NAKAHARA, K
INAMURA, N
GOTO, T
机构：
[1] FUJISAWA PHARMACEUT CO LTD,OSAKA 532,JAPAN
[2] SAKURA NATL HOSP,SAKURA,JAPAN
来源：
TRANSPLANTATION | 1987年 / 44卷 / 06期
关键词：
D O I：
10.1097/00007890-198712000-00001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：729 / 733
页数：5
相关论文
共 50 条
  • [41] Limbal allografting using FK-506
    Rao, SK
    Rajagopal, R
    Fogla, R
    Sitalakshmi, G
    Padmanabhan, P
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (12) : 1409 - 1410
  • [42] A NOVEL FK506 BINDING-PROTEIN CAN MEDIATE THE IMMUNOSUPPRESSIVE EFFECTS OF FK506 AND IS ASSOCIATED WITH THE CARDIAC RYANODINE RECEPTOR
    LAM, E
    MARTIN, MM
    TIMERMAN, AP
    SABERS, C
    FLEISCHER, S
    LUKAS, T
    ABRAHAM, RT
    OKEEFE, SJ
    ONEILL, EA
    WIEDERRECHT, GJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) : 26511 - 26522
  • [43] Effects of FK506 in rat and human resistance arteries
    De Lima, JJG
    Xue, H
    Coburn, L
    Andoh, TF
    McCarron, DA
    Bennett, WM
    Roullet, JB
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1518 - 1527
  • [44] Tacrolimus pharmacology and nonclinical studies: From FK506 to protopic
    Bekersky, I
    Lilja, H
    Lawrence, I
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2001, 20 (04) : 226 - 232
  • [45] Neuroimmunophilin ligands promote neuroprotection in a model of MS: Effects of FK506 and a nonimmunosuppressant FK506 derivative (FR131706) in eae
    Gold, BG
    Voda, J
    Yu, X
    McKeon, G
    Yamaji, T
    Matsuoka, N
    Bourdette, DN
    MULTIPLE SCLEROSIS, 2004, 10 (01):
  • [46] Crystal structure of the FK506 binding domain of human FKBP25 in complex with FK506
    Prakash, Ajit
    Rajan, Sreekanth
    Yoon, Ho Sup
    PROTEIN SCIENCE, 2016, 25 (04) : 905 - 910
  • [47] Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients
    Furth, S
    Neu, A
    Colombani, P
    Plotnick, L
    Turner, ME
    Fivush, B
    PEDIATRIC NEPHROLOGY, 1996, 10 (01) : 64 - 66
  • [48] A comparative study of FK506 granules and capsules in renal transplant recipients
    Takahara, S
    Miki, T
    Hatori, M
    Hokado, Y
    Wang, JD
    Okuyama, A
    TRANSPLANT INTERNATIONAL, 1998, 11 (03) : 181 - 185
  • [49] Neurotoxicity in pediatric renal transplant recipients treated with FK506 (tacrolimus).
    Neu, AM
    Furth, SL
    Case, BW
    Wise, B
    Colombani, PM
    Fivush, BA
    PEDIATRIC RESEARCH, 1996, 39 (04) : 2177 - 2177
  • [50] Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients
    McKee, M
    Segev, D
    Wise, B
    Case, B
    Neu, A
    Fivush, B
    Colombani, P
    JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (05) : 688 - 690
12345